Breaking News, Promotions & Moves

Nona Biosciences Appoints Dr. Di Hong CEO

Hong will help drive strategic growth and technology innovation with over 20 years of experience.

By: Rachel Klemovitch

Assistant Editor

Nona Biosciences (Nona), a global biotechnology company providing integrated solutions from “Idea to IND” (I to ITM), appointed Dr. Di Hong as Chief Executive Officer (CEO). Dr. Hong will be based in Shanghai and report directly to Dr. Jingsong Wang, Chairman of Nona Biosciences. In this role, Dr. Hong will lead Nona’s next stage of growth by strengthening its highly efficient service system, advancing technology innovation, integrating AI and external investment, and furthe...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters